Identification and quantification of serum KIN17 protein based on ELISA assay and exploring its clinical diagnostic value in liver cancer-Reference-Cited by-同舟云学术

Identification and quantification of serum KIN17 protein based on ELISA assay and exploring its clinical diagnostic value in liver cancer

Published:2024 Issue:28 Volume:16 Page:4724-4732
ISSN:1759-9660
Container-title:Analytical Methods
language:en
Short-container-title:Anal. Methods

Author:

Su Ruiqi¹²^ORCID,Chu Lok Ting³,Chen Zhenkai¹²,Lin Xiaocong³^ORCID,Peng Minghui²,Huang Xueran²,Xiao Xiangyan²,Zeng Tao¹²^ORCID

Affiliation:

1. Department of Medical Laboratory, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China

2. Laboratory Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, P. R. China

3. Institute of Biochemistry and Molecular Biology, Guangdong Medical University, Zhanjiang, Guangdong, P. R. China

Abstract

In this work, we confirmed that the presence of KIN17 protein in serum and developed a quantitative analysis method. It showed that KIN17 protein is highly expressed in liver cancer serum and is expected to become a new serological tumor marker.

Funder

Basic and Applied Basic Research Foundation of Guangdong Province

Medical Science and Technology Foundation of Guangdong Province

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/AY/D4AY00793J

Reference33 articles.

1. A global view of hepatocellular carcinoma: trends, risk, prevention and management

2. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calculus bovis in hepatocellular carcinoma: Tumor molecular basis, Wnt/β-catenin pathway role, and protective mechanism;World Journal of Gastroenterology;2024-09-21